Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer

INTRODUCTION: Despite durable responses from immune-checkpoint blockade (ICB) in a subset of patients with advanced non-small cell lung cancer (NSCLC), the majority of patients do not derive benefit from this treatment. In this analysis we evaluated the impact of concomitant administration of antibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huemer, Florian, Rinnerthaler, Gabriel, Westphal, Theresa, Hackl, Hubert, Hutarew, Georg, Gampenrieder, Simon Peter, Weiss, Lukas, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893258/
https://www.ncbi.nlm.nih.gov/pubmed/29662663
http://dx.doi.org/10.18632/oncotarget.24751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893258/
https://www.ncbi.nlm.nih.gov/pubmed/29662663
http://dx.doi.org/10.18632/oncotarget.24751

Ejemplares similares